ACT | adoptive cell therapy |
CAR-T cell | chimeric antigen receptor T cell |
GMP | good manufacture practice |
DC | dendritic cell |
EVA | ethyl vinyl acetate |
FEP | fluorinated ethylene propylene |
HFBR | hollow-fiber bioreactor |
MSCs | mesenchymal stem cells |
NK | natural killer |
PBL | peripheral blood lymphocyte |
PoC | point-of-care |
TIL | tumor infiltrating lymphocyte |